FDA approves first test for screening Zika virus in blood donations

["U.S. Food and Drug Administration" <fda@xxxxxxxxxx>]

If your email program has trouble displaying this email, view it as a web page

	FDA approves first test for screening Zika virus in blood donations
	The U.S. Food and Drug Administration today approved the cobas Zika test, a qualitative nucleic acid test for the detection of Zika virus RNA in individual plasma specimens obtained from volunteer donors of whole blood and blood components, and from living organ donors. It is intended for use by blood collection establishments to detect Zika virus in blood donations, not for the individual diagnosis of Zika virus infection. Continue reading.

U.S. Food and Drug Administration
10903 New Hampshire Avenue, Silver Spring, MD 20993
1-888-INFO-FDA (1-888-463-6332)
Privacy Policy | www.fda.gov
Manage Preferences or Unsubscribe from this List | Unsubscribe from all Email Lists